Continuous and early prediction of future moderate and severe Acute Kidney Injury in critically ill patients: Development and multi-centric, multi-national external validation of a machine-learning model.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: An hourly machine-learning model predicted future stage 2/3 acute kidney injury across 16,760 ICU patients from 145 centers in three countries, with multicenter external validation reported.
Technology: An hourly machine-learning model predicted future stage 2/3 acute kidney injury across 16,760 ICU patients from 145 centers in three countries, with multicenter external validation reported.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- An hourly machine-learning model predicted future stage 2/3 acute kidney injury across 16,760 ICU patients from 145 centers in three countries, with multicenter external validation reported.
- Limitation / still unknown
- Multicenter external validation supports prediction across the reported ICU data; prospective clinical deployment and improved AKI outcomes were not demonstrated.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1371/journal.pone.0287398
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.